Maxim Group initiated coverage on Zivo Bioscience with a new price target
$ZIVO
Biotechnology: Pharmaceutical Preparations
Health Care
Maxim Group initiated coverage of Zivo Bioscience with a rating of Buy and set a new price target of $9.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/15/2021 | $9.00 | Buy | Maxim Group |
8-K - Zivo Bioscience, Inc. (0001101026) (Filer)
10-Q - Zivo Bioscience, Inc. (0001101026) (Filer)
DEF 14A - Zivo Bioscience, Inc. (0001101026) (Filer)